Drug Shortage Report for SANDOZ FENOFIBRATE S
Report ID | 112410 |
Drug Identification Number | 02288052 |
Brand name | SANDOZ FENOFIBRATE S |
Common or Proper name | SANDOZ FENOFIBRATE S |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FENOFIBRATE |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90 FCT BO |
ATC code | C10AB |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2020-04-10 |
Estimated end date | Unknown |
Actual end date | 2020-04-08 |
Shortage status | Avoided shortage |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2023-11-17 | French | Compare |
v3 | 2023-11-17 | English | Compare |
v2 | 2020-04-16 | French | Compare |
v1 | 2020-04-16 | English | Compare |
Showing 1 to 4 of 4